Cargando…
QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
PURPOSE: A Quality-adjusted Time WIthout Symptoms of disease or Toxicity (QTWiST) analysis was carried out to assess quality-adjusted survival time in the RECOURSE trial of trifluridine/tipiracil versus placebo in pretreated metastatic colorectal cancer (mCRC). METHODS: Duration of overall survival...
Autores principales: | Tabernero, Josep, Van Cutsem, Eric, Ohtsu, Atsushi, Amellal, Nadia, Cadour, Stéphanie, Fougeray, Ronan, Haffemayer, Benjamin, Mayer, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708318/ https://www.ncbi.nlm.nih.gov/pubmed/29211817 http://dx.doi.org/10.1136/esmoopen-2017-000284 |
Ejemplares similares
-
Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis
por: Tabernero, Josep, et al.
Publicado: (2020) -
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
por: Yoshino, T., et al.
Publicado: (2020) -
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
por: Van Cutsem, Eric, et al.
Publicado: (2017) -
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis
por: Yoshino, T., et al.
Publicado: (2022) -
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial
por: Van Cutsem, Eric, et al.
Publicado: (2017)